Retinitis pigmentosa: current clinical management and emerging therapies

XTA Nguyen, L Moekotte, AS Plomp… - International Journal of …, 2023 - mdpi.com
Retinitis pigmentosa (RP) comprises a group of inherited retinal dystrophies characterized
by the degeneration of rod photoreceptors, followed by the degeneration of cone …

Reticular pseudodrusen: a critical phenotype in age-related macular degeneration

Z Wu, EL Fletcher, H Kumar, U Greferath… - Progress in retinal and …, 2022 - Elsevier
Reticular pseudodrusen (RPD), or subretinal drusenoid deposits (SDD), refer to distinct
lesions that occur in the subretinal space. Over the past three decades, their presence in …

Age-related macular degeneration

M Fleckenstein, TDL Keenan, RH Guymer… - Nature reviews Disease …, 2021 - nature.com
Age-related macular degeneration (AMD) is the leading cause of legal blindness in the
industrialized world. AMD is characterized by accumulation of extracellular deposits, namely …

The AI revolution in glaucoma: bridging challenges with opportunities

F Li, D Wang, Z Yang, Y Zhang, J Jiang, X Liu… - Progress in Retinal and …, 2024 - Elsevier
Recent advancements in artificial intelligence (AI) herald transformative potentials for
resha** glaucoma clinical management, improving screening efficacy, sharpening …

Hydroxychloroquine-induced retinal toxicity

IH Yusuf, P Charbel Issa, SJ Ahn - Frontiers in Pharmacology, 2023 - frontiersin.org
Long-term use of hydroxychloroquine can cause retinopathy, which may result in severe and
progressive visual loss. In the past decade, hydroxychloroquine use has markedly increased …

[HTML][HTML] Age-related macular degeneration, a mathematically tractable disease

CA Curcio, D Kar, C Owsley… - … & Visual Science, 2024 - jov.arvojournals.org
A progression sequence for age-related macular degeneration onset may be determinable
with consensus neuroanatomical nomenclature augmented by drusen biology and eye …

AI in the clinical management of GA: a novel therapeutic universe requires novel tools

GS Reiter, J Mai, S Riedl, K Birner, S Frank… - Progress in Retinal and …, 2024 - Elsevier
Regulatory approval of the first two therapeutic substances for the management of
geographic atrophy (GA) secondary to age-related macular degeneration (AMD) is a major …

[HTML][HTML] Full-field stimulus testing: role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease

AJ Roman, AV Cideciyan, V Wu, AV Garafalo… - Progress in Retinal and …, 2022 - Elsevier
Disease mechanisms have become better understood in previously incurable forms of early-
onset severe retinal dystrophy, such as Leber congenital amaurosis (LCA). This has led to …

Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future

LA Levin, C Patrick, NB Choudry, NA Sharif… - Frontiers in …, 2022 - frontiersin.org
Background Neurological and ophthalmological neurodegenerative diseases in large part
share underlying biology and pathophysiology. Despite extensive preclinical research on …

[HTML][HTML] CRB1-associated retinal dystrophies: a prospective natural history study in anticipation of future clinical trials

M Talib, MJ van Schooneveld, J Wijnholds… - American Journal of …, 2022 - Elsevier
PURPOSE To investigate the natural disease course of retinal dystrophies associated with
crumbs cell polarity complex component 1 (CRB1) and identify clinical end points for future …